| Stem definition | Drug id | CAS RN |
|---|---|---|
| antiviral, monoclonal antibodies | 5433 | 2375952-29-5 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
EBANGA (ansuvimab-zykl) is a Zaire ebolavirus (EBOV) glycoprotein 1 (GP1)-directed recombinant, human IgG1kappa monoclonal antibody that binds to the glycan cap and inner chalice of the EBOV GP1 subunit. The epitope to which it binds is located within the receptor binding domain of EBOV consisting of amino acids LEIKKPDGS (GP residues 111–119).
|
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Dec. 21, 2020 | FDA | RIDGEBACK BIOTHERAPEUTICS |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | J06BD04 | ANTIINFECTIVES FOR SYSTEMIC USE IMMUNE SERA AND IMMUNOGLOBULINS IMMUNOGLOBULINS Antiviral monoclonal antibodies |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000998 | Antiviral Agents |
| FDA MoA | N0000194037 | Zaire Ebolavirus Glycoprotein-directed Antibody Interactions |
| FDA EPC | N0000194038 | Zaire Ebolavirus Glycoprotein-directed Antibody |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Ebola virus disease | indication | 37109004 | DOID:4325 |
None
None
None
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Envelope glycoprotein | Glycoprotein | ANTIBODY BINDING | Kd | 9.70 | DRUG LABEL | DRUG LABEL |
| ID | Source |
|---|---|
| D11875 | KEGG_DRUG |
| TG8IQ19NG2 | UNII |
| C5432324 | UMLSCUI |
| CHEMBL4594388 | ChEMBL_ID |
| DB16385 | DRUGBANK_ID |
| 018606 | NDDF |
| 1149150009 | SNOMEDCT_US |
| 1149244009 | SNOMEDCT_US |
| 2472151 | RXNORM |
| C000711947 | MESH_SUPPLEMENTAL_RECORD_UI |
| 11568 | INN_ID |
None